The research that matters, without the jargon.

Peer-reviewed breakthroughs in plain English alongside verified outcomes, evidence grades, and clinical study details for everyone from everyday readers to medical students.

ClearMed Editorial Digest500 briefings across 12 specialties121 Phase III & clinical practice

Indexed from PubMed, NEJM, The Lancet, JAMA, Nature MedicineSaved Library

Health Hubs:

Stage: Evidence:

Showing 3 briefings matching “lipid”

Reset all filters

Immunology

Immunology Clinical Briefings

Peer-Reviewed Clinical Digests · Verified Scientific Media

IMMUNOLOGY · PRECLINICAL

Compartment-specific PPARδ activity controls the outcome of cancer-immune cell competition and immunotherapy efficacy

These findings identify compartment-specific PPARδ activity as a targetable driver of immune cell fitness that can be harnessed to improve outcomes in immunotherapy-resistant tumors. Therapeutically, PPARδ-activated CD8 + T cells sensitize immunotherapy-resistant microsatellite stable metastatic colorectal cancer to checkpoint blockade in mice, and pharmacological or genetic PPARδ activation enhances human chimeric antigen receptor T cell function.

2/5 Preclinical

Evidence Meter · 2/5

Animal & Preclinical Data

Demonstrated in living animal models before large-scale human safety and dosing trials begin.

1 min readNature ImmunologyNov 14, 2026

IMMUNOLOGY · REAL-WORLD COHORT

Spatial transcriptomics in immune-mediated necrotising myopathy uncovers a specific necrotic signature related to immune-driven fibrosis

In conclusion, IMNM necrotic muscle areas are linked to a specific SFRP4-expressing fibroblast subtype interacting with macrophages, potentially driving the pathological muscle phenotype and contributing to inflammation, fibro-fatty replacement, and strength loss. These cells carried a strong proportion of IMNM-enriched pathological signatures, notably a complement-linked 'tumour-like' inflammatory fibroblast signature and a specific interferon (an immune-signaling protein) response, characterised by the expression of metallothioneins.

3/5 Observational

Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readAnnals of the Rheumatic DiseasesOct 30, 2026

IMMUNOLOGY · REAL-WORLD COHORT

Population-scale reconstruction of menopause dynamics reveals a physiological cliff at the final menstrual period

These findings support a systemic, quantifiable view of menopause and provide a generalizable strategy for recovering hidden biological trajectories applicable to other transitions such as puberty or disease progression. Dysregulation began more than a decade before FMP.

3/5 Observational

Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readNature MedicineOct 12, 2026

Interactive Fact Check